Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 3, 2012, Pages 935-940

  Bozinovski, Steven ^a   Uddin, Mohib ^b   Vlahos, Ross ^a   Thompson, Michelle ^c   McQualter, Jonathan L ^a   Merritt, Anne Sophie ^a   Wark, Peter A B ^d,e   Hutchinson, Anastasia ^c   Irving, Louis B ^c   Levy, Bruce D ^b   Anderson, Gary P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e JOHN HUNTER HOSPITAL   (Australia)

Author keywords

G protein coupled receptor; Innate immunity; Leukocyte activation; Resolution

Indexed keywords

CD68 ANTIGEN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; DEXAMETHASONE; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LIPOCORTIN 1; LIPOXENE A; LIPOXENE A4; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM AMYLOID A; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LUNG LAVAGE; MACROPHAGE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REFRACTORY PERIOD; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIAL CELLS; EPITHELIUM; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-8; LIPOXINS; LUNG; MACROPHAGES; MICE; MUCOUS MEMBRANE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; SERUM AMYLOID A PROTEIN;

MURINAE;

EID: 84856401514     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1109382109     Document Type: Article

References (33)

1. Barnes PJ, Adcock IM (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373:1905-1917.
2. Willemse BW, et al. (2005) Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 26:835-845. (Pubitemid 41632040)
3. Pauwels RA, Rabe KF (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613-620.
4. Spira A, et al. (2004) Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA 101:10143-10148. (Pubitemid 38891209)
5. Serhan CN, Savill J (2005) Resolution of inflammation: The beginning programs the end. Nat Immunol 6:1191-1197. (Pubitemid 43045627)
6. Vachier I, et al. (2005) Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol 115:55-60. (Pubitemid 40075421)
7. Haworth O, Levy BD (2007) Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 30:980-992. (Pubitemid 351194804)
8. Su SB, et al. (1999) A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 189:395-402. (Pubitemid 29063260)
9. El Kebir D, et al. (2007) Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J Immunol 179:616-622. (Pubitemid 46986579)
10. He R, Sang H, Ye RD (2003) Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101:1572-1581. (Pubitemid 36182537)
11. Bozinovski S, et al. (2008) Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:269-278. (Pubitemid 351198369)
12. Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA (2006) Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:71-78. (Pubitemid 43069790)
13. Bonnans C, Fukunaga K, Levy MA, Levy BD (2006) Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am J Pathol 168:1064-1072.
14. Perretti M, et al. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8:1296-1302. (Pubitemid 35373563)
15. Sethi S (2000) Infectious etiology of acute exacerbations of chronic bronchitis. Chest 117(5, Suppl 2):380S-385S.
16. Kluve-Beckerman B, Drumm ML, Benson MD (1991) Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol 10:651-661.
17. Marsche G, et al. (2007) The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I. Biochem J 402:117-124.
18. Okamoto H, Katagiri Y, Kiire A, Momohara S, Kamatani N (2008) Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. J Rheumatol 35:752-756. (Pubitemid 351747112)
19. Sandri S, et al. (2008) Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol 83:1174-1180 (Pubitemid 351960349)
20. Cheng N, He R, Tian J, Ye PP, Ye RD (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 181:22-26.
21. Levy BD, et al. (2007) Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J 21:3877-3884. (Pubitemid 350232345)
22. Levy BD, et al.; Severe Asthma Research Program, National Heart, Lung, and Blood Institute (2005) Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 172:824-830. (Pubitemid 41369064)
23. Morris T, et al. (2010) Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc Natl Acad Sci USA 107:8842-8847.
24. Chiang N, et al. (2006) The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 58:463-487. (Pubitemid 44394909)
25. Dufton N, et al. (2010) Anti-inflammatory role of the murine formyl-peptide receptor 2: Ligand-specific effects on leukocyte responses and experimental inflammation. J Immunol 184:2611-2619.
26. Chen Y, Chen P, Hanaoka M, Droma Y, Kubo K (2008) Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 13:1014-1021.
27. Sawmynaden P, Perretti M (2006) Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes. Biochem Biophys Res Commun 349:1351-1355. (Pubitemid 44430195)
28. Mullan RH, et al. (2006) Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum 54:105-114. (Pubitemid 43122193)
29. O'Hara R, Murphy EP, Whitehead AS, FitzGerald O, Bresnihan B (2004) Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum 50:1788-1799. (Pubitemid 38725091)
30. Fyfe AI, et al. (1997) Association between serum amyloid A proteins and coronary artery disease: Evidence from two distinct arteriosclerotic processes. Circulation 96: 2914-2919. (Pubitemid 27500090)
31. Thorn CF, Lu ZY, Whitehead AS (2003) Tissue-specific regulation of the human acutephase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells. Eur J Immunol 33:2630-2639. (Pubitemid 37138994)
32. Thorn CF, Whitehead AS (2002) Differential glucocorticoid enhancement of the cytokine- driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2. J Immunol 169:399-406. (Pubitemid 34686161)
33. Culpitt SV, et al. (2003) Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:24-31. (Pubitemid 36015913)